Luciano Frontini

Author PubWeight™ 14.20^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.	J Natl Cancer Inst	2003	3.41
2	Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.	J Natl Cancer Inst	2007	2.42
3	Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.	Lancet Oncol	2005	2.36
4	Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.	J Clin Oncol	2005	2.11
5	Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group.	J Clin Oncol	2003	2.09
6	Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alternating schedule' study findings.	Eur J Cancer	2008	0.85
7	Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial.	Lung Cancer	2008	0.76
8	Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II study.	Oncology	2005	0.76
9	[The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?].	Tumori	2008	0.75
10	Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II study.	Anticancer Drugs	2006	0.75